E-LIB Suche - Ergebnisse für: Rolleri, Robert

1

Bimekizumab Impact on Pain in Moderate to Severe Hidradenit..:

Orenstein, Lauren A.V ; Shi, Vivian ; Lev-Tov, Hadar...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s350 , 2024

Link: https://doi.org/10.25251..

2

P080 Bimekizumab efficacy and impact on pain in moderate-to..:

Ingram, John R ; Orenstein, Lauren A V ; Shi, Vivian Y...
British Journal of Dermatology. 191 (2024) Supplement_1 - p. i52-i52 , 2024

Link: https://doi.org/10.1093/..

3

Bimekizumab Response Maintenance to 48 Weeks in Patients wi..:

Ingram, John R. ; Porter, Martina ; Chovatiya, Raj...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s396 , 2024

Link: https://doi.org/10.25251..

4

Efficacy and safety of bimekizumab in patients with moderat..:

Kimball, Alexa B ; Jemec, Gregor B E ; Sayed, Christopher J...
The Lancet. 403 (2024) 10443 - p. 2504-2519 , 2024

Link: https://doi.org/10.1016/..

5

Electronic Patient-Reported Outcomes in Hidradenitis Suppur..:

Ingram, John R. ; Ciaravino, Valerie ; Rolleri, Robert...
Dermatology. 240 (2023) 1 - p. 65-76 , 2023

Link: https://doi.org/10.1159/..

6

Certolizumab pegol for the treatment of chronic plaque psor..:

Lebwohl, Mark ; Blauvelt, Andrew ; Paul, Carle...
Journal of the American Academy of Dermatology. 79 (2018) 2 - p. 266-276.e5 , 2018

Link: https://doi.org/10.1016/..

7

Certolizumab Pegol for the Treatment of Patients with Moder..:

Blauvelt, Andrew ; Reich, Kristian ; Lebwohl, Mark...
SKIN The Journal of Cutaneous Medicine. 2 (2018) - p. S3 , 2018

Link: https://doi.org/10.25251..

8

Certolizumab Pegol for the Treatment of Chronic Plaque Psor..:

Piguet, Vincent ; Blauvelt, Andrew ; Burge, Daniel...
SKIN The Journal of Cutaneous Medicine. 1 (2017) - p. s3 , 2017

Link: https://doi.org/10.25251..

9

Budesonide Foam Has a Favorable Safety Profile for Inducing..:

Rubin, David T. ; Sandborn, William J. ; Bosworth, Brian...
Digestive Diseases and Sciences. 60 (2015) 11 - p. 3408-3417 , 2015

Link: https://doi.org/10.1007/..

10

Budesonide Foam Induces Remission in Patients With Mild to ..:

Sandborn, William J. ; Bosworth, Brian ; Zakko, Salam...
Gastroenterology. 148 (2015) 4 - p. 740-750.e2 , 2015

Link: https://doi.org/10.1053/..

11

Sa1195 Patient Reported Outcome Measures Derived From the C..:

Khanna, Reena ; D'Haens, Geert R. ; Feagan, Brian G....
Gastroenterology. 146 (2014) 5 - p. S-226 , 2014

Link: https://doi.org/10.1016/..

12

Mo1173 Safety Analysis of Budesonide Foam for Inducing Remi..:

Rubin, David T. ; Sandborn, William ; Bosworth, Brian P....
Gastroenterology. 146 (2014) 5 - p. S-577 , 2014

Link: https://doi.org/10.1016/..

13

P-149 Efficacy and Safety of Budesonide Foam for Inducing R..:

Sandborn, William ; Bosworth, Brian ; Zakko, Salam...
Inflammatory Bowel Diseases. 19 (2013) - p. S83 , 2013

Link: https://doi.org/10.1097/..

14

O-002 Evaluation of the Operating Properties of Candidate P..:

Khanna, Reena ; D'Haens, Geert ; Feagan, Brian...
Inflammatory Bowel Diseases. 19 (2013) - p. S1-S2 , 2013

Link: https://doi.org/10.1097/..

15

Dose Proportionality and the Effects of Food on Bioavailabi..:

Bass, Almasa ; Stark, Jeffrey G. ; Pixton, Glenn C....
Clinical Therapeutics. 34 (2012) 7 - p. 1601-1612 , 2012

Link: https://doi.org/10.1016/..